Search

Search Constraints

You searched for: Author/Creator Neumann, Uta

Search Results

2. Rationale of a lower dexamethasone dose in prenatal congenital adrenal hyperplasia therapy based on pharmacokinetic modelling. Issue 3 (3rd August 2021)

3. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children. Issue 4 (October 2020)

4. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry. (11th July 2022)

5. Response to 'Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia'. Issue 6 (December 2020)

6. International practice of corticosteroid replacement therapy in congenital adrenal hyperplasia: data from the I-CAH registry. Issue 4 (April 2021)

7. Self- and proxy-reported outcomes after surgery in people with disorders/differences of sex development (DSD) in Europe (dsd-LIFE). Issue 3 (June 2021)

8. Absorption and tolerability of taste‐masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. (7th September 2017)

9. The genetic diagnosis of rare endocrine disorders of sex development and maturation: a survey among Endo-ERN centres. Issue 12 (14th November 2022)

10. Paediatric population pharmacokinetic modelling to assess hydrocortisone replacement dosing regimens in young children. Issue 4 (October 2020)